Kuang Zhihui, Lin Lin, Kong Ranran, Wang Zhonghua, Mao Xianjun, Xiang Dingcheng
Department of Cardiology, The First People's Hospital of Chenzhou, Chenzhou, 423000, Hunan, China.
The First Clinical College of Jinan University,Jinan University, Guangzhou, 510000, Guangdong, China.
Sci Rep. 2025 Jan 2;15(1):253. doi: 10.1038/s41598-024-84125-5.
Coronary artery spasm (CAS) is a key contributor to the pathogenesis of acute ST-segment elevation myocardial infarction (STEMI). While smoking is recognized as a major risk factor for CAS, the relationship between cumulative cigarette consumption and infarction-related CAS across different age groups in STEMI patients remains unclear. This study aimed to investigate the correlation between cumulative cigarette consumption and infarction-related CAS across different age groups through a retrospective analysis. This retrospective study included STEMI patients who underwent coronary angiography (CAG) at the General Hospital of Southern Theater Command, between December 2014 and March 2018. STEMI was diagnosed based on the 2017 European Society of Cardiology (ESC) guidelines. Patients were divided into CAS and non-CAS groups according to CAG results, and further categorized by age into three groups: young (≤ 45 years), middle-aged (46-59 years), and elderly (≥ 60 years). Cumulative cigarette consumption was calculated using the smoking index (cigarettes/day × years). Smoking status was graded as follows: grade 0 (non-smokers), grade 1 (index ≤ 100), grade 2 (index > 100 and ≤ 200), and grade 3 (index > 200). Statistical analyses, including Chi-square tests, Spearman correlation, and multivariate logistic regression were conducted to evaluate the relationship between smoking and CAS in different age groups. Among the 1156 STEMI patients analyzed, 80 (6.9%) were diagnosed with CAS. The CAS group exhibited a higher proportion of young adults (35.0% vs. 13.8%, P < 0.001) and grade 3 smokers (62.5% vs. 46.6%, P < 0.001) compared to the non-CAS group. A positive correlation between cumulative cigarette consumption and CAS was observed in all patients (r = 0.124, P < 0.001), heavy smoking (grade 2 and grade 3) was significantly associated with CAS in young adults (r = 0.321, P < 0.001) and middle-aged adults (r = 0.127, P = 0.006) but not in elderly patients. Logistic regression demonstrated that heavy smoking significantly increased CAS risk, with adjusted odds ratios of 6.397 for grade 2 smokers and 6.926 for grade 3 smokers, relative to non-smokers. Among heavy smokers( grade 2 and grade 3), young adults had a 4.912-fold higher CAS risk, while middle-aged adults had a 2.041-fold higher risk, compared to elderly individuals. Cumulative cigarette consumption is closely linked to infarction-related CAS in STEMI patients. Heavy smoking (grade 2 and grade 3) is a key factor linked to infarction-related coronary spasm, especially in younger and middle-aged adults. Effective smoking control is essential for preventing and managing STEMI, particularly among younger and middle-aged populations in China. Further validation of our findings using prospective studies and large registries is warranted.
冠状动脉痉挛(CAS)是急性ST段抬高型心肌梗死(STEMI)发病机制的关键因素。虽然吸烟被认为是CAS的主要危险因素,但在STEMI患者中,不同年龄组的累积吸烟量与梗死相关CAS之间的关系仍不清楚。本研究旨在通过回顾性分析调查不同年龄组累积吸烟量与梗死相关CAS之间的相关性。这项回顾性研究纳入了2014年12月至2018年3月期间在南部战区总医院接受冠状动脉造影(CAG)的STEMI患者。根据2017年欧洲心脏病学会(ESC)指南诊断STEMI。根据CAG结果将患者分为CAS组和非CAS组,并按年龄进一步分为三组:青年(≤45岁)、中年(46 - 59岁)和老年(≥60岁)。使用吸烟指数(每天吸烟支数×年数)计算累积吸烟量。吸烟状况分级如下:0级(非吸烟者)、1级(指数≤100)、2级(指数>100且≤200)和3级(指数>200)。进行了包括卡方检验、Spearman相关性分析和多因素逻辑回归在内的统计分析,以评估不同年龄组吸烟与CAS之间的关系。在分析的1156例STEMI患者中,80例(6.9%)被诊断为CAS。与非CAS组相比,CAS组中年轻人的比例更高(35.0%对13.8%,P<0.001),3级吸烟者的比例更高(62.5%对46.6%,P<0.001)。在所有患者中观察到累积吸烟量与CAS之间存在正相关(r = 0.124,P<0.001),重度吸烟(2级和3级)在年轻人(r = 0.321,P<0.001)和中年人(r = 0.127,P = 0.006)中与CAS显著相关,但在老年患者中不相关。逻辑回归表明,重度吸烟显著增加CAS风险,相对于非吸烟者,2级吸烟者的调整优势比为6.397,3级吸烟者为6.926。在重度吸烟者(2级和3级)中,与老年人相比,年轻人发生CAS的风险高4.912倍,中年人高2.041倍。累积吸烟量与STEMI患者梗死相关CAS密切相关。重度吸烟(2级和3级)是与梗死相关冠状动脉痉挛相关的关键因素,尤其是在年轻人和中年人中。有效的吸烟控制对于预防和管理STEMI至关重要,特别是在中国的年轻人和中年人群体中。有必要使用前瞻性研究和大型登记处对我们的研究结果进行进一步验证。